CABA — Cabaletta Bio Cashflow Statement
0.000.00%
Last trade - 00:00- $590.55m
- $480.59m
Annual cashflow statement for Cabaletta Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -46.3 | -53 | -67.7 | -116 | -168 |
| Depreciation | |||||
| Non-Cash Items | 5.87 | 9.72 | 12.6 | 21.2 | 35.5 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 5.58 | -4.3 | 0.101 | 1.61 | -0.379 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -34.1 | -46.4 | -53.5 | -88.2 | -131 |
| Capital Expenditures | -1.17 | -2.45 | -0.687 | -2.21 | -1.23 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 7.17 | -24.8 | -21.8 | 49.5 | -49 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 6 | -27.2 | -22.5 | 47.3 | -50.3 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 48.9 | 33 | 188 | 11.7 | 100 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 20.8 | -40.6 | 112 | -29.3 | -81 |